Neogen (NEOG) Cash from Operations Growth (1y) (2011 - 2026)
Neogen (NEOG) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn | 122.43% |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn | 16.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 16.66% |
| Nov 30, 2025 | -51.70% |
| Aug 31, 2025 | 160.58% |
| May 31, 2025 | -38.52% |
| Feb 28, 2025 | 164.43% |
| Nov 30, 2024 | 156.16% |
| Aug 31, 2024 | -177.86% |
| May 31, 2024 | -70.60% |
| Feb 29, 2024 | -76.96% |
| Nov 30, 2023 | 183.92% |
| Aug 31, 2023 | 262.69% |
| May 31, 2023 | 346.13% |
| Feb 28, 2023 | -358.97% |
| Nov 30, 2022 | -204.93% |
| Aug 31, 2022 | -160.93% |
| May 31, 2022 | -7.19% |
| Feb 28, 2022 | -43.16% |
| Nov 30, 2021 | -20.29% |
| Aug 31, 2021 | -7.65% |
| May 31, 2021 | -14.28% |